Medical Device News Magazine

Ivenix Selects Eastman Tritan™ Copolyester for its New Infusion System

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Medical technology innovator Ivenix collaborated with Eastman to incorporate Eastman Tritan MXF copolyester into its groundbreaking Ivenix Infusion System. The new system includes a large-volume infusion pump, a portfolio of administration sets, and a suite of IV management tools and analytics to inform care and advance clinical and operational efficiency.

Ivenix selected Tritan MXF for the pump exterior because of its excellent chemical resistance and durability in the face of the aggressive disinfection protocols needed to prevent the spread of healthcare-associated infections (HAIs).

“The Ivenix Infusion System has several key advantages over our competition—one being its durability in real-world clinical environments,” said Josh North, director of sales at Ivenix. “The ability to stand up to the short kill-time disinfectants like quaternary ammonium and ammonium chloride resonates with infection prevention and patient safety teams. Also, our pumps successfully endure the ‘tough love’ experienced in day-to-day clinical use, and this has a real impact on repair costs and downtime for our customers.”

Because Tritan MXF is resistant to a larger number of disinfectants, infection preventionists can rest easy knowing that they can choose from a variety of cleaners and wipes that won’t adversely impact their devices. This simplifies cleaning protocols and alleviates worries about voiding warranties because the wrong cleaner was used.

Among hospital patients, 90% require the use of infusion pumps, critical medical devices that deliver fluids such as essential nutrients and medications into a patient’s body in controlled amounts. They are also the number one medical device plagued with significant safety issues related to failures. Infusion pump failures—such as broken components, corrosion of electric pins and even cracks, no matter the size—can compromise the safe use of pumps and lead to catastrophic outcomes for patients.

Infusion pumps, like many medical devices, are constantly handled by multiple people, are moved across many environments, and can get dropped or bumped on hard surfaces. Frequent cleaning, like that endured by medical devices (often on an hourly basis), can weaken typical polymers used in device housings, making them brittle and more likely to crack.

Recognizing the link between chemical resistance, impact and device failure, Ivenix needed a polymer for the pump’s exterior housing that would address all these issues. The company selected Tritan MXF early in the design process, because it demonstrates the right combination of properties to provide lightweight durability and chemical resistance.

Eastman’s medical polymers enable Ivenix to deliver an infusion pump that is stronger and more disinfectant ready, contributing to more consistent device performance, longevity and, ultimately, patient safety. To learn more about how material choice impacts IV pump failures and cleaning the Ivenix Infusion System, visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”